For example, germline heterozygous mutations in genes directly implicated in HR—BRCA1, BRCA2, PALB2, RAD51C and RAD51D—increase the risk of ovarian and breast cancer [22,23,24,25]. This evidence concerns the gene BRCA2 and breast carcinoma.